Under this scheme, applications may be processed more swiftly if certain conditions are met:
No reported deaths or serious injuries associated with the device, both locally and worldwide.
No active recalls, field safety corrective actions, or adverse incidents related to the device, locally and worldwide.
Approval from at least two independent regulatory agencies, such as the U.S. FDA, EU CE, TGA (Australia), Health Canada, or Japan's PMDA/MHLW.
If these criteria are satisfied, the MDD may expedite the review process. Applicants are required to respond to any issues raised by the MDD within two weeks after receiving notice
For applications that do not qualify for expedited processing, the general processing time can range from 2 to 6 months, depending on the volume of applications and the need for additional information.
Applications should be submitted to:
Medical Device Division (MDD)
Department of Health
Units 2–3, 11/F, Energy Plaza
92 Granville Road
Tsim Sha Tsui East, Kowloon
Hong Kong
.jpg)
Whatsapp or Wechat:+86 15816864648;email address:hito.lin@grzan.cn